Progestogen-only pills and high blood pressure: Is there an association?: A literature review

Contraception

Volumn 69, Issue 2, 2004, Pages 89-97

  Hussain, Sabina F ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Blood pressure; Hypertension; Oral contraceptive; Progestogen only pill

Indexed keywords

DESOGESTREL; ETYNODIOL DIACETATE; LEVONORGESTREL; LOW DOSE ORAL CONTRACEPTIVE; MESTRANOL PLUS NORETHISTERONE; NORETHISTERONE; NORGESTREL;

CLINICAL TRIAL; COCHRANE LIBRARY; CORONARY RISK; DISEASE ASSOCIATION; HORMONAL CONTRACEPTION; HUMAN; INFORMATION RETRIEVAL; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; MEDICAL LITERATURE; MEDLINE; ORAL CONTRACEPTION; PATIENT SELECTION; PUBLICATION; REVIEW; RISK FACTOR; SAMPLE SIZE; SYSTOLIC HYPERTENSION; UTILIZATION REVIEW;

EID: 0842281501     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2003.09.002     Document Type: Review

References (15)

1. rd ed. London: Churchill Livingstone, 1999. p. 266-301.
2. Chasan-Taber L, Willett WC, Manson JE, et al. Prospective study of oral contraceptives and hypertension among women in the United States. Circulation 1996;94:483-9.
3. Barcelona XB. Depo-Provera contraceptive may increase risk of cardiovascular disease [BMJ news roundup]. BMJ 2002;325:513.
4. Blumenstein BA, Douglas MB, Hall WD. Blood pressure changes and oral contraceptive use: a study of 2676 black women in the south-eastern United States. Am J Epidemiol 1980;112:539-52.
5. O'Brien P. Third generation oral contraceptives. Postmarketing surveillance does not catch all adverse events. BMJ 1996;312:577.
6. Heinemann LAJ, Assmann A, DoMinh T, Garbe E. Oral progestogen-only contraceptive and cardiovascular risk: results from the Transnational Study on Oral Contraceptives and the health of young women. Eur J Contracept Reprod Health Care 1999;4:67-73.
7. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined oral contraceptives. Contraception 1998;57:315-24.
8. Dong W, Coulhon HM, Poulter NR. Blood pressure in women using oral contraceptives: results from the Health Survey of England. J Hypertens 1997;1063-8.
9. Spellacy WN, Birk BS. The effect of intrauterine devices, oral contraceptives, estrogens, and progestogens and blood pressure. Am J Obstet Gynecol 1972;112:912-9.
10. Wilson ESB, Cruikshank J, McMaster M, Weir RJ. A prospective controlled study of the effect on the blood pressure of contraceptive preparations containing different types and dosages of progestogen. Br J Obstet Gynecol 1984;91:1254-60.
11. Hall WD, Douglas MB, Blumenstein B, Hatcher RA. Blood pressure and oral progestational agents. A prospective study of 119 black women. Am J Obstet Gynecol 1980;136:344-8.
12. Weir RJ. Effect on blood pressure of changing from high to low dose steroid preparations in women with oral contraceptive induced hypertension. Scott Med J 1982;27:212-5.
13. nd ed. London: Churchill Livingstone, 2000. p 155-67.
14. WHO medical eligibility criteria. Available at: www.who.int/reproductive- health/publications. Accessed March 30, 2003.
15. Levels of evidence, March 2002. Available at: www.eboncall.co.uk/content/ levels.html. Accessed on March 27, 2003.